ESPE Abstracts

ESPE Abstracts

Published by BioScientifica
Previous issue | Volume 84 | ESPE2015 | Next issue

54th Annual ESPE (ESPE 2015)

Barcelona, Spain
01 Oct 2015 - 03 Oct 2015

Card image cap
Barcelona, Spain; 1-3 October 2015 Further information

Poster Category 2

GH & IGF

Previous section
Fat
Table of contents
Next section
Gonads

hrp0084p2-392 | GH & IGF

Unaltered Ratio of Circulating Levels of GH Isoforms after Administration of Different GH Provocative Tests in a Population of Short Stature Children

hrp0084p2-393 | GH & IGF

Study of IGF1 Receptor Gene in Small for Gestational Age Patients with Short Stature Treated with RHGH

hrp0084p2-394 | GH & IGF

Gene Expression Profiles in GH Deficient Children Relate Peak GH Levels to Circadian Clock, Chromatin Remodelling, and WNT Signalling Pathways

hrp0084p2-395 | GH & IGF

Growth and GH in Kabuki Syndrome

hrp0084p2-396 | GH & IGF

Abstract unavailable

hrp0084p2-397 | GH & IGF

Silver Russell syndrome: A Cause of Partial IGF1 Resistance?

hrp0084p2-398 | GH & IGF

The In vitro Functional Analysis of Gene Promoter Region Single Nucleotide Polymorphisms Associated with GH Response in Children with GH Deficiency

hrp0084p2-399 | GH & IGF

Is Retesting in GH Deficient Children Really Useful?

hrp0084p2-400 | GH & IGF

Regulation of IGF1R mRNA Expression by GnRH Agonist may be Involved in the Decrease of Height Velocity During Central Precocious Puberty Therapy

hrp0084p2-401 | GH & IGF

GRB10 Knockdown in Zebrafish is Associated with Decreased Weight-to-length Ratio without Alterations in AKT and ERK Activity: A Model to Study Human Growth Regulation

hrp0084p2-402 | GH & IGF

The Involvement of the Epidermal Growth Factor Receptor in the Successful GH Signalling and the Role of p21 in the Negative Regulation of the GH/GHR and EGF/EGFR Pathways, in GH Transduction Defect

hrp0084p2-403 | GH & IGF

Homozygous Carriers of a Novel IGFALS Mutation are 1.5 SD Shorter than Heterozygous Relatives and Tend to have Lower Bone Mineral Density

hrp0084p2-404 | GH & IGF

The Role of β-TrCP, an E3 Ubiquitin Ligase, in the Signalling of the GH and Epidermal Growth Factor Pathways in Growth Hormone Transduction Defect

hrp0084p2-405 | GH & IGF

SGA Short Stature Bearing with a Novel Nonsense Mutation (p.W1249X) in the IGF1R Gene

hrp0084p2-406 | GH & IGF

Metabolic Health in Short Children Born Small for Gestational Age Treated with GH and GnRHa: Results of a Randomised, Dose-response Trial

hrp0084p2-407 | GH & IGF

A Phase 2, 6-Month, Randomised, Active-Controlled, Safety and Efficacy Study of TransCon hGH Compared to Daily Human GH in Children with GH Deficiency

hrp0084p2-408 | GH & IGF

Does Skeletal Disproportion in Children with Idiopathic Short Stature Influence Response to GH Therapy?

hrp0084p2-409 | GH & IGF

The Influence of GH Therapy on Chemerin Concentration, Body Mass and Selected Parameters of Carbohydrate Metabolism in Prepubertal Non-Obese Children with GH Deficiency

hrp0084p2-410 | GH & IGF

Response to GH Treatment in the Very Young with GH Deficiency

hrp0084p2-411 | GH & IGF

Estimation of Adipsin, Omentin and Vaspin Concentration in Prepubertal Children with GH Deficiency before and after 6 Months of GH Treatment

hrp0084p2-412 | GH & IGF

Final Height and Safety Outcomes in GH-Treated Children Born Small for Gestational Age: Experience from the Prospective GeNeSIS Observational Study

hrp0084p2-413 | GH & IGF

Results up to January 2015 from PATRO Children, a Multi-Centre, Non-Interventional Study of the Long-Term Safety and Efficacy of Omnitrope® in Children Requiring GH Treatment

hrp0084p2-414 | GH & IGF

GH Treatment Prevents Hypoxia-Induced Decrease of GH and IGF1 Plasma Concentrations in Neonatal Mice

hrp0084p2-415 | GH & IGF

The Pharmacokinetics and Pharmacodynamics of TV-1106, a Once Weekly GH Supplement: Results from a Phase 2 Study of TV-1106 in Adults with GH Deficiency

hrp0084p2-416 | GH & IGF

Effects of GH Treatment on the Heart in Children with GH Deficiency

hrp0084p2-417 | GH & IGF

GH Therapy in Skeletal Dysplasias: Final Height Data

hrp0084p2-418 | GH & IGF

Random Forest Classification Predicts Response to Recombinant GH in GH Deficient Children Using Baseline Clinical Parameters and Genetic Markers

hrp0084p2-419 | GH & IGF

Safety Evaluation of Long-Term Recombinant GH Treatment in Childhood: Interim Analysis of the NordiNet® International Outcome Study (IOS)

hrp0084p2-420 | GH & IGF

Hypoglycaemic Adverse Events Reported in Children Enrolled in the European Increlex® Growth Forum Database in Europe (5-Year Interim Data)

hrp0084p2-421 | GH & IGF

Application of Neural Networks for Final Height Prediction Based on Pre-Treatment Data in Children with GH Deficiency Treated with GH

hrp0084p2-422 | GH & IGF

Physical Performance and Right Ventricular Function in Children with GH Deficiency before and after 12 Months-GH Replacement Therapy

hrp0084p2-423 | GH & IGF

The Accuracy of Bioelectrical Impedance Analysis to Detect the Body Composition Changes in Adolescents with Severe GHD During Transition

hrp0084p2-424 | GH & IGF

Timing of GH Peak in Provocation Tests is Important in Predicting the Effectiveness of Treatment with rhGH in Prepubertal Children with GHD

hrp0084p2-425 | GH & IGF

Comparison of Baseline Parameters and Response to GH Treatment in 125 Children with Short Stature with Eight Different Diagnosis

hrp0084p2-426 | GH & IGF

The Acid-Labile Subunit Dose Matters? Response to Human GH Treatment in Patients with Acid-Labile Subunit Deficiency

hrp0084p2-427 | GH & IGF

rhGH Replacement Therapy Ameliorates Body Composition Substantially but has No Effect in the Quality of Life in Adolescents with GH deficiency – A Cross-Sectional Study

hrp0084p2-428 | GH & IGF

Evaluation of the Effect of GH Treatment on Insulin Resistance and Cardiovascular Tissue

hrp0084p2-429 | GH & IGF

Effectiveness of Recombinant IGF1 Treatment in a Patient with Isolated GH IA Deficit Producer of Anti-GH Antibodies

hrp0084p2-430 | GH & IGF

Analysis of CD133+CD45+ Hematopoietic Progenitor/Stem Cells and CD133+/CD45- Very Small Embryonic-Like Stem Cells in Children with GH Deficiency Subjected to GH Therapy

hrp0084p2-431 | GH & IGF

Effectiveness of rhIGF1 Treatment in a Girl with Leprechaunism

Published by BioScientifica

ESPE Abstracts

© Bioscientifica 2025 | Privacy policy | Cookie settings

BiosciAbstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more